LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.60 | 27.76 | 1111 | 7045 | 0.1577 | 0.5871 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.60 | 27.76 | 11078 | 7045 | 1.5723 | 1.1166 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.31 | 27.76 | 7655 | 6976 | 1.0973 | 1.0234 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.31 | 27.76 | 8112 | 6976 | 1.1628 | 1.0382 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.31 | 27.76 | 1265 | 6976 | 0.1813 | 0.6145 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 80.31 | 27.76 | 11268 | 6976 | 1.6152 | 1.1240 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.01 | 27.76 | 7449 | 7000 | 1.0641 | 1.0156 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.01 | 27.76 | 8194 | 7000 | 1.1705 | 1.0399 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.01 | 27.76 | 1253 | 7000 | 0.1790 | 0.6121 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 82.01 | 27.76 | 11493 | 7000 | 1.6418 | 1.1282 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 83.72 | 27.76 | 7262 | 7055 | 1.0292 | 1.0072 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 83.72 | 27.76 | 8236 | 7055 | 1.1673 | 1.0391 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 83.72 | 27.76 | 1236 | 7055 | 0.1752 | 0.6082 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 83.72 | 27.76 | 11629 | 7055 | 1.6482 | 1.1291 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 85.42 | 27.76 | 6955 | 7025 | 0.9899 | 0.9975 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 85.42 | 27.76 | 8343 | 7025 | 1.1875 | 1.0435 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 85.42 | 27.76 | 1301 | 7025 | 0.1852 | 0.6192 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 85.42 | 27.76 | 11886 | 7025 | 1.6918 | 1.1362 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.13 | 27.76 | 6557 | 6987 | 0.9383 | 0.9841 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.13 | 27.76 | 8419 | 6987 | 1.2048 | 1.0473 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.13 | 27.76 | 1215 | 6987 | 0.1739 | 0.6061 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 87.13 | 27.76 | 12089 | 6987 | 1.7300 | 1.1423 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.84 | 27.76 | 5247 | 6965 | 0.7533 | 0.9302 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.84 | 27.76 | 8466 | 6965 | 1.2155 | 1.0496 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 88.84 | 27.76 | 1168 | 6965 | 0.1677 | 0.5986 | MN20160318_Q01 | K18 |